61 results
424B3
CTMX
CytomX Therapeutics Inc
25 Aug 23
Prospectus supplement
5:36pm
in the Securities Act and is therefore unenforceable.
The above provisions may discourage stockholders from bringing a lawsuit against our directors for breach
424B5
kbpb7kk5gy8 owm
4 Mar 22
Prospectus supplement for primary offering
5:22pm